Seres Therapeutics, Inc.

NASDAQ:MCRB

Biotechnology

Healthcare
$5.28 +1.70%

+$0.11 today

Market cap
$51.13M
Beta
0.11
P/E (TTM)
-1.3
EPS (TTM)
-$4.89
52W Low $5.31High $29.98

Volume 0.04M

Average 0.06M

Income Statement

Follow revenue through to earnings.

Revenue

$789,000.00

FY 2025 · Annual

Operating Income

-$93.97M

FY 2025 · Annual

Net Income

$5.70M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue144.93M000789K
Cost of Revenue0019.34M3.53M4.13M
Gross Profit144.93M0(19.34M)(3.53M)(3.34M)
Gross Margin100.0%———-423.8%
Research & Development141.89M109.65M117.6M64.6M49.06M
Selling, General & Admin69.26M70.26M77.5M53.18M39.16M
Operating Expenses209.42M179.91M175.76M117.78M90.63M
Depreciation & Amortization5.95M6.63M6.24M5.47M4.13M
EBITDA(56.72M)(170.93M)(181.42M)(120.3M)9.83M
EBITDA Margin-39.1%———1245.8%
Operating Income(64.49M)(179.91M)(195.1M)(121.32M)(93.97M)
Operating Margin-44.5%———-11910.1%
Interest Income2.87M3.06M7.3M3.97M2.23M
Interest Expense2.91M6.02M13.18M00
Other Income / Expenses(1.09M)(3.67M)4.97M(4.46M)99.67M
Income Before Tax(65.58M)(183.58M)(190.13M)(125.77M)5.7M
Pre-Tax Margin-45.2%———721.9%
Income Tax Expense00000
Net Income(65.58M)(250.16M)(113.72M)(146.57M)5.7M
Net Margin-45.2%———721.9%
EPS (Basic)(14.30)(46.29)(17.77)(18.86)0.64
EPS (Diluted)(14.30)(46.29)(17.77)(18.86)0.64
Weighted Avg Shares4.59M5.4M6.4M7.77M8.86M
Weighted Avg Shares (Diluted)4.59M5.4M6.4M7.77M8.87M

MCRB Earnings Waterfall · TTM

NASDAQ:MCRB · Revenue to Net Income

Key Ratios

EPS$-5.17
Gross Margin-142.6%
Net Margin-1681.5%
P/E Ratio0.2
P/S Ratio254.6

Analysis

$1.1M of revenue converted into -$46.9M of net income for the selected period. Gross margin is -142.6% and net margin is -1681.5%, showing how much revenue survives after costs and taxes. EPS is $-5.17, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
EFFECTEFFECT filingAug 21, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026

How much revenue does MCRB generate?

Seres Therapeutics, Inc. (MCRB) reported $789,000.00 of revenue in fiscal 2025.

Is MCRB profitable?

Seres Therapeutics, Inc. (MCRB) reported $5.70M of net income, with a net margin of 721.9%.